13 results

• Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis

  August 20, 2026

  Irvin Jackson

  A California woman's Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug's cancer risks, but refused to inform doctors and patients.

• Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges

  August 11, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.

• CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use

  July 29, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims that the manufacturer intentionally failed to warn patients or the medical community about the eczema treatment's potential cancer risks.

• Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis

  July 21, 2026

  Irvin Jackson

  A Dupixent cancer lawsuit claims the manufacturers failed to adequately test and label the eczema treatment, resulting in a CTCL cancer diagnosis.

• Lawsuit Claims Dupixent Cancer Diagnosis Occurred After Only 8 Months of Use

  June 17, 2026

  Irvin Jackson

  The makers of Dupixent face a CTCL lawsuit by a man who says he developed the rare form of cancer less than a year after beginning treatment with the eczema drug.

• Dupixent Injection Lawsuit Alleges Manufacturer Failed to Warn About T-Cell Lymphoma Cancer Side Effects

  June 4, 2026

  Irvin Jackson

  Regeneron and Sanofi-Aventis face a Dupixent injection lawsuit from a Louisiana woman who says the companies knew about the drug's risks but downplayed them to doctors and patients.

• Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis

  May 28, 2026

  Michael Adams

  A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.

• Link Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges

  May 11, 2026

  Michael Adams

  A lawsuit alleges an Illinois woman developed CTCL after using Dupixent, raising concerns the manufacturer may have withheld concerns that the drug could contribute to cancer.

• Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy

  May 1, 2026

  Irvin Jackson

  A Dupixent lawsuit claims use of the drug led to the diagnosis of two forms of CTCL cancer, requiring repeated chemotherapy treatment and life-long medical monitoring.

• Enlarged Lymph Nodes Led to Dupixent CTCL Diagnosis, Lawsuit Claims

  March 16, 2026

  Irvin Jackson

  The makers of Dupixent face a lawsuit from a Florida woman who says she developed CTCL after just a month of injections of the atopic dermatitis treatment.